Skip to search.
 TSX Down 0.03% TSX Ventures Up 0.42%

Nektar Therapeutics (NKTR)

-NasdaqGS
14.90 Up 0.10(0.68%) May 26, 4:00PM EDT
|After Hours : 14.90 Down 0.00 (0.01%) May 26, 4:21PM EDT
Prev Close:14.80
Open:14.79
Bid:11.62 x 500
Ask:15.25 x 1300
1y Target Est:17.43
Beta:1.03767
Earnings Date:Aug 3 - Aug 8 (Est.)
Day's Range:14.56 - 14.91
52wk Range:9.16 - 17.55
Volume:700,321
Avg Vol (3m):1,161,400
Market Cap:2.03B
P/E (ttm):N/A
EPS (ttm):-1.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
NKTRUp 0.68%2.03B
GSKDown 0.07%104.67B
ENZNDown 2.69%17.60M
BMYUp 0.06%118.07B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.15
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.97
Quarterly EPS Est (Jun-16) :-0.32
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):1.89

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nektar Therapeutics develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising oncology, pain, anti-infectives... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback